Authors: | Giralt, S.; Seifter, E. |
Article Title: | Case-based roundtable on treatment approach for young, fit, newly diagnosed multiple myeloma patients |
Abstract: | With the advent new proteasome inhibitors (carfilzomib, ixazomib), new immune-modulatory drugs (pomalidomide), and new monoclonal antibodies (elotuzimab, daratumumab) as approved treatments for myeloma, the therapeutic landscape for this disease has changed. In this chapter, using a case-based approach, I will provide a personal guide of how I approach myeloma therapy in a transplant eligible patient in 2018. © 2018 by The American Society of Hematology. All rights reserved. |
Journal Title: | Hematology-American Society of Hematology Education Program |
Volume: | 2018 |
Issue: | 1 |
ISSN: | 1520-4391 |
Publisher: | American Society of Hematology |
Date Published: | 2018-11-30 |
Start Page: | 103 |
End Page: | 109 |
Language: | English |
DOI: | 10.1182/asheducation-2018.1.103 |
PROVIDER: | scopus |
PMCID: | PMC6245961 |
PUBMED: | 30504298 |
DOI/URL: | |
Notes: | Hematology Am Soc Hematol Educ Program -- Export Date: 2 January 2019 -- Review -- Source: Scopus C2 - 30504298 |